市場調查報告書
商品編碼
1466033
下一代隱形眼鏡和輔助器具視器市場:按產品、按疾病分類 - 全球預測 2024-2030 年Next Generation Contact Lenses & Visual Prostheses Market by Product, Disease - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
下一代隱形眼鏡和輔助器具市場規模預計到2023年為2.1471億美元,2024年達到2.5445億美元,2030年達到7.1557億美元,複合年成長率預計為18.76%。
下一代隱形眼鏡包括各種先進的功能和材料,增強了傳統視力矯正以外的功能。其中包括採用智慧技術設計的隱形眼鏡,這些技術可實現互動式視覺覆蓋、健康監測感測器、藥物輸送系統以及透過先進材料和設計來提高舒適度和視力等功能。視覺假體是醫療設備,旨在幫助因視網膜色素變性或老齡化黃斑部病變等疾病而導致視力喪失或視力障礙的人恢復功能性視力。這些設備的工作原理通常是繞過受損的感光器,直接刺激視覺系統的其餘功能部分,例如視網膜、視神經和視覺皮層。人口老化的加劇、眼部相關疾病發病率的增加以及對非侵入性醫療設備的需求不斷增加正在促進市場擴張。然而,高昂的市場開拓和製造成本以及醫療設備核准的嚴格監管要求可能會阻礙市場成長。然而,監測健康指標的智慧隱形眼鏡開拓、根據患者個體需求製造設備的客製化技術、改善視覺假體功能的 3D 列印技術和人工智慧演算法的市場仍在不斷湧現,預計這些整合將創造潛在機會。一代隱形眼鏡和視覺假體市場擴張。
主要市場統計 | |
---|---|
基準年[2023] | 21471萬美元 |
預測年份 [2024] | 2.5445億美元 |
預測年份 [2030] | 71557萬美元 |
複合年成長率(%) | 18.76% |
產品 治療性隱形眼鏡正迅速應用於術後護理和各種角膜疾病的治療。
診斷或監測隱形眼鏡是先進的眼科設備,旨在非侵入性測量眼壓、血糖濃度和淚液成分等生理參數。藥物釋放型隱形眼鏡旨在將藥物直接控制釋放到眼睛中,為治療感染疾病、過敏和乾眼等眼部疾病提供一種新方法。這些鏡片浸有治療劑,與傳統眼藥水相比,可提高藥物接觸時間、增加生物有效性、減少全身性副作用、提高患者依從性和治療效果。治療性隱形眼鏡旨在治療和控制眼表疾病和損傷。它為角膜提供保護屏障,促進癒合,並可以輸送藥物。視覺假體或「仿生眼」旨在幫助因視網膜疾病而嚴重視力喪失或失明的人恢復視力。這些系統由連接在眼鏡上的攝影機、視訊處理單元和電刺激視覺系統的植入組成。皮質植入是一種視覺假體,完全繞過眼球,瞄準大腦視覺皮質。該裝置將視覺訊息轉換為直接髮送到大腦視覺皮質的電刺激模式,目的是恢復因眼球、視神經或皮質前視覺途徑受損而喪失視力的人的視覺感知。視神經植入是一種視覺假體,旨在直接刺激視神經,將視覺訊息從視網膜傳送到大腦。當視網膜出現故障,但神經和下游視覺途徑保持完好時,通常會考慮這種情況。視網膜植入取代退化視網膜細胞的功能,主要用於治療老齡化黃斑部病變和色素性視網膜炎等視網膜疾病。這些植入捕捉光並將其轉化為電訊號,刺激剩餘的視網膜細胞並向大腦發送視覺訊息。
用於治療老齡化黃斑部病變的下一代隱形眼鏡和視覺假體的採用持續成長
老齡化黃斑部病變是 50 歲以上族群視力喪失的主要原因。其特徵是視網膜中央部分(稱為黃斑部)劣化,影響中央視力。有乾式和濕式兩種漸進式。新一代視覺假體和隱形眼鏡正在研究中,它們可以放大剩餘視力,向視網膜輸送藥物以減緩其進展,或結合與視網膜神經迴路連接的微型相機來恢復視力。糖尿病眼科疾病,主要是糖尿病性視網膜病變和糖尿病黃斑部水腫,是由視網膜血管損傷引起的糖尿病併發症。隱形眼鏡技術的最新進展包括可以透過淚液監測血糖濃度的鏡片,這可能有助於糖尿病管理。青光眼是一組損害視神經的眼科疾病,通常與眼內壓升高有關。未經治療的青光眼會導致不可逆轉的視力喪失。帶有內建感測器的隱形眼鏡已經開發出來,可以連續監測眼壓水平,提供一種非侵入性的方法來控制和減緩青光眼的進展。青光眼患者的視覺假體可用於刺激受損視神經以外的視覺途徑。色素性視網膜炎是一種影響視網膜的遺傳性疾病,導致視力逐漸喪失和夜盲症。在假眼領域,在製造仿生眼植入以取代視網膜退化的光感受器功能方面取得了重大進展。在隱形眼鏡方面,研究重點是含有微電子的鏡片,以增強可用視力並提供光療以減緩 RP 的進展。
區域洞察
美洲地區較高的消費者認知度、強勁的經濟以及醫療設備的保險覆蓋範圍促進了市場需求的成長。人們對具有血糖監測和擴增實境(AR) 等先進功能的智慧隱形眼鏡的興趣正在刺激一些新興企業和研發舉措。此外,人們對先進醫療設備的興趣與日俱增,私人公司和學術機構的舉措正在推動美洲視覺修復和增強眼科設備的創新解決方案。在歐盟國家,由於與數位螢幕相關的活動增加和人口老化,對高級隱形眼鏡的需求正在增加。醫療設備法規 (MDR) 等監管指令形成了業界標準。由歐盟研究和創新框架計劃資助的正在進行的計劃表明了我們對尖端眼科技術的承諾。在中東,這些先進的醫療設備正在逐漸被採用,並且非常注重奢華和品質。該地區的醫療保健投資正在成長,政府致力於改善醫療保健基礎設施。亞太地區呈現出多樣化的市場動態,龐大的人口基數推動了消費者對視力矯正和保護的需求。用於健康監測和生活方式需求的智慧隱形眼鏡越來越受歡迎,該地區的投資重點是利用製造能力來降低成本並提高可及性。
FPNV定位矩陣
FPNV 定位矩陣對於評估新一代隱形眼鏡和輔助器具市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對下一代隱形眼鏡和視覺輔助器具市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4.競爭力評估與資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1.下一代隱形眼鏡和輔助器具市場的市場規模和預測是多少?
2.在下一代隱形眼鏡和視覺輔助器具市場的預測期內,有哪些產品、細分市場、應用和領域需要考慮投資?
3.下一代隱形眼鏡和輔助器具市場的技術趨勢和法規結構是什麼?
4.下一代隱形眼鏡和輔助器具市場主要供應商的市場佔有率是多少?
5. 進入下一代隱形眼鏡和輔助器具市場的適當型態和策略性手段是什麼?
[197 Pages Report] The Next Generation Contact Lenses & Visual Prostheses Market size was estimated at USD 214.71 million in 2023 and expected to reach USD 254.45 million in 2024, at a CAGR 18.76% to reach USD 715.57 million by 2030.
Next generation contact lenses encompass a variety of advanced features and materials that enhance functionality beyond conventional vision correction. These include contact lenses designed with smart technology that may enable interactive visual overlays, health monitoring sensors, drug delivery systems, and improved comfort and vision through advanced materials or designs. Visual prostheses are medical devices designed to restore functional vision for individuals suffering from vision loss or impairment caused by conditions such as retinitis pigmentosa or age-related macular degeneration. These devices often work by bypassing damaged photoreceptors and directly stimulating the remaining functional parts of the visual system, including the retina, optic nerve, or visual cortex. Increasing an aging population, the rise in eye-related diseases, and the growing demand for non-invasive medical devices contribute to market expansion. However, high costs of development and production coupled with stringent regulatory requirements for medical device approval may impede market growth. Nevertheless, the development of smart contact lenses that monitor health indicators and the integration of AI algorithms to improve the functionality of visual prostheses with customization and 3D printing technologies to produce devices tailored to individual patients' needs is expected to create potential opportunities for the next generation contact lenses and visual prostheses market expansion.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 214.71 million |
Estimated Year [2024] | USD 254.45 million |
Forecast Year [2030] | USD 715.57 million |
CAGR (%) | 18.76% |
Product: Burgeoning adoption of therapeutic contact lenses proving invaluable in post-surgical care and treatment of various corneal conditions
Diagnostic or monitoring contact lenses are advanced ocular devices designed to measure physiological parameters, such as intraocular pressure, glucose levels, and tear composition, in a non-invasive manner. Drug-eluting contact lenses are engineered to provide a controlled release of medications directly into the eye, offering a novel approach to treating ocular conditions such as infections, allergies, and dry eyes. These lenses are impregnated with therapeutic agents and aim to improve drug contact time, enhance bioavailability, and reduce systemic side effects as compared to traditional eye drops, improving patient compliance and treatment efficacy. Therapeutic contact lenses are designed to treat and manage ocular surface disorders and injuries. They are a protective barrier over the cornea, promote healing, and can deliver drugs. Visual prostheses, or "bionic eyes," aim to restore vision to individuals with severe vision loss or blindness due to retinal diseases. These systems consist of a camera mounted on glasses, a video processing unit, and an implant that electrically stimulates the visual system. A cortical implant is a type of visual prosthesis that bypasses the eye entirely and targets the brain's visual cortex. The device translates visual information into electrical stimulation patterns delivered directly to the brain's visual cortex, intending to restore visual perception to those who have lost sight due to ocular, optic nerve, or pre-cortical visible pathway damage. An optic nerve implant is a visual prosthesis designed to stimulate the optic nerve directly, which gives visual information from the retina to the brain. This is typically considered when the retina has become non-functional; however, the nerve and downstream visual pathway remain intact. Retinal implants replace degenerated retinal cells' functionality and are primarily used to treat retinal diseases, including age-related macular degeneration and retinitis pigmentosa. These implants capture light and convert it into electrical signals, stimulating the remaining retinal cells to send visual information to the brain.
Disease: Evolving adoption of next-generation contact lenses and visual prostheses for age-related macular degeneration
Age-related macular degeneration is the foremost reason for vision loss in individuals aged 50 and above. It is characterized by the deterioration of the retina's central portion, known as the macula, which affects central vision. Advanced forms include dry and wet AMD. New generations of visual prostheses and contact lenses are being researched to amplify the remaining vision, deliver drugs to the retina to slow the progression, or even incorporate miniature cameras that interface with the neural circuitry of the retina to restore vision. Diabetic eye diseases, primarily diabetic retinopathy and diabetic macular edema, are complications of diabetes caused by damage to blood vessels in the retina. The latest advancements in contact lens technology include lenses that can monitor glucose levels through tears, potentially aiding diabetes management. Glaucoma is a cluster of eye conditions that damage the optic nerve, often linked to heightened intraocular pressure. Untreated glaucoma can lead to irreversible blindness. Contact lenses with embedded sensors are being developed to continuously monitor intraocular pressure levels, providing a non-invasive method to manage and deter glaucoma progression. Visual prostheses for glaucoma patients could be adopted to stimulate the visual pathway beyond the damaged optic nerve. Retinitis pigmentosa is a genetic disorder affecting the retina, causing gradual vision loss and night blindness. In the realm of prosthetics, significant progress has been made in creating bionic eye implants that substitute the function of degenerated photoreceptors in the retina. For contact lenses, research focuses on lenses that include microelectronics to enhance the available vision or to deliver light therapy to slow the progression of RP.
Regional Insights
The Americas region's high consumer awareness, strong economy, and insurance coverage for medical devices contribute to increased market demand. Interest in smart contact lenses with advanced features such as glucose monitoring and augmented reality has spurred several startups and R&D initiatives. Furthermore, there is an inclination towards advanced medical devices, with initiatives by both the private sector and academic institutions pushing forward innovative solutions in visual prostheses and enhanced ocular devices in the Americas. EU countries are witnessing a growing demand for advanced contact lenses due to increased activities related to digital screens and an aging populace. Regulatory directives such as the Medical Device Regulation (MDR) shape industry standards. Ongoing projects funded by the EU Framework Programmes for Research and Innovation showcase the commitment to cutting-edge ocular technology. The Middle East is gradually adopting these advanced medical devices, with a strong focus on luxury and quality. The region's healthcare investment is scaling, characterized by government initiatives to improve healthcare infrastructure. The Asia-Pacific region exhibits diverse market dynamics, with the region's large population base driving consumer needs for vision correction and protection, which is compounded by an aging demographic in certain countries. Smart contact lenses that cater to health monitoring and lifestyle needs are gaining popularity, and investments in the region are focused on leveraging manufacturing prowess to reduce costs and improve accessibility.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Next Generation Contact Lenses & Visual Prostheses Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Next Generation Contact Lenses & Visual Prostheses Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Next Generation Contact Lenses & Visual Prostheses Market, highlighting leading vendors and their innovative profiles. These include ABB Optical Group, Alcon Vision LLC, Bausch & Lomb Incorporated, Bionic Vision Technologies, Chromagen Europe B.V., CooperVision, Inc., HOYA Corporation, INTEROJO CO. LTD., Johnson & Johnson Vision Care, Inc., Luneau Technology Operations SAS, Menicon Co., Ltd., Miami Contact Lens, Mojo Vision Inc., Nidek Co., Ltd., Novartis AG, Orion Vision Group, PERVICE CO., LTD., Pixium Vision SA, Sensimed SA, Spectrum International, STAAR Surgical Company, SwissLens S.A., SynergEyes, Inc., XPANCEO RESEARCH ON NATURAL SCIENCE L.L.C., and ZEISS Group.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Next Generation Contact Lenses & Visual Prostheses Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Next Generation Contact Lenses & Visual Prostheses Market?
3. What are the technology trends and regulatory frameworks in the Next Generation Contact Lenses & Visual Prostheses Market?
4. What is the market share of the leading vendors in the Next Generation Contact Lenses & Visual Prostheses Market?
5. Which modes and strategic moves are suitable for entering the Next Generation Contact Lenses & Visual Prostheses Market?